Library | LabRulez ICPMS

Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

Applications

| 2023 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis by ICP Atomic Emission Spectrometry in Accordance with the ICH Q3D Guideline for Elemental Impurities Using ICPE-9820

Applications

| 2015 | Shimadzu

MP/ICP-AES

Instrumentation

MP/ICP-AES

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

Applications

| 2022 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Measuring Elemental Impurities in Pharmaceutical Materials

Brochures and specifications

| 2022 | Agilent Technologies

Consumables, ICP/MS, ICP/OES

Instrumentation

Consumables, ICP/MS, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution

Technical notes

| 2021 | Agilent Technologies

Software, ICP/OES

Instrumentation

Software, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Applications

| 2020 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Technical notes

| 2014 | Agilent Technologies

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

Analysis by ICP Atomic Emission Spectrometry in Accordance with the ICH Q3D Guideline for Elemental Impurities Using ICPE-9820

Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Measuring Elemental Impurities in Pharmaceutical Materials

USP <232>/<233> and ICH Q3D Elemental Impurities Analysis: The Agilent ICP-OES Solution

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Related content

Insight into the nucleosome recognition mechanisms

An outstanding scientist, Prof. Vladimír Sklenář, has passed away (* 16 April 1951 - † 13 April 2024)

Scientists from IOCB Prague have improved materials for reconstructive and plastic surgery